METHOD OF ANGIOPATHY DEVELOPMENT RISK DIAGNOSTICS IN ARTERIAL HYPERTENSION CASES WITH METABOLIC SYNDROME Russian patent published in 2008 - IPC G01N33/50 

FIELD: medicine.

SUBSTANCE: invention can be applied to angiopathy development risk diagnostics in arterial hypertension (AH) cases with metabolic syndrome (MS). Essentially, thrombocyte aggregative activity with collagen, antithrombin III level, euglobuline lysis time, and nitrate level in patient blood are determined, before and during temporal venous occlusion. Then vascular wall antiaggregatory activity index (VWAAI), vascular antithrombin III synthesis index (VASI), vascular wall fibrinolytic activity index (VWFAI), and nitrate index (NI) are calculated. After this, vascular antithrombotic index (VATI) by formula: VATI = (VWAAI + VASI + VWFAI + NI)/4 is calculated. If the value achieves 2.27 and more, angiopathy development risk is eliminated; if 2.26-2.10, the patients are included in angiopathy development risk group; if 2.09 and less, angiopathy develops.

EFFECT: increase in prediction accuracy of the disease development risk, possibility to administer adequate treatment in good time.

2 tbl, 3 ex, 1 dwg